SPY414.92-5.67 -1.35%
DIA332.96-5.20 -1.54%
IXIC14,030.38-130.97 -0.92%

Stoke Therapeutics Q1 EPS $(0.46) Down From $(0.34) YoY

Stoke Therapeutics (NASDAQ:STOK) reported quarterly losses of $(0.46) per share. This is a 35.29 percent decrease over losses of $(0.34) per share from the same period last year.

05/10/2021 07:37
Stoke Therapeutics (NASDAQ:STOK) reported quarterly losses of $(0.46) per share. This is a 35.29 percent decrease over losses of $(0.34) per share from the same period last year.